MARISSA KAPANEK: Open Payments
NPI 1538795083 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 23 payments from 9 companies in 2025. Trend: 2023 $515 · 2024 $719 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 13 | $285 |
| Astellas Pharma US Inc | 2 | $42 |
| Medtronic, Inc. | 2 | $40 |
| Biogen, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| MILLICENT US INC | 1 | $23 |
| Organon LLC | 1 | $21 |
| Exeltis, USA Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: ANNOVERA, Veozah, TRUCLEAR, ZURZUVAE, MYFEMBREE, FEMLYV, NEXPLANON, SLYND.
Industry payments across NY — which companies pay providers there.
